Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Manuel Rubio‐Rivas, Xavier Corbella, Alfredo Guillén-del-Castillo, Carles Tolosa Vilella, Dolores Colunga Argüelles, Ana Argibay, José Antonio Vargas‐Hitos, José Antonio Parra, Cristina González-Echávarri, Norberto Ortego‐Centeno, Luis Trapiella Martínez, Mónica Rodríguez‐Carballeira, Adela Marín Ballvé, Xavier Pla Salas, Isabel Perales Fraile, Antonio-J Chamorro, Ana Belén Madroñero Vuelta, M. Freire, Manuel Ruiz Muñoz, Andrés González García, Isaac Pons Martín del Campo, María Esther Sánchez García, David Bello, Gerard Espinosa, Francisco José García Hernández, Luís Sáez-Comet, Juan José Ríos Blanco, Rafael Ángel Fernández de la Puebla Giménez, Sabela Sánchez Trigo, Vicent Fonollosa, Carmen Pilar Simeón‐Aznar
Topics & Concepts
MedicineScleroderma (fungus)CohortInternal medicineMultivariate analysisFramingham Risk ScoreMultivariate statisticsProportional hazards modelSystemic sclerodermaCohort studySurgeryPathologyDermatomyositisStatisticsDiseaseMathematicsInoculationSystemic Sclerosis and Related DiseasesDermatologic Treatments and ResearchMast cells and histamine